Fig. 4

Time course of HbA1c in type 1 and type 2 diabetes mellitus patients. (a) HbA1c in type 1 patients (●) and (b) HbA1c in type 2 patients (▲) after switching from glargine or detemir to degludec. Data are mean ± SD (bars) for all assigned participants. Comparisons were made by ANOVA